Anavex Life Sciences Corp (AVXL)

[rocalinda]

From today's PR:

.....Rettsyndrome.org today announced that Rettsyndrome.org has committed a financial grant of a minimum of $0.6 million to cover the majority of a planned U.S. multicenter Phase 2 clinical trial of ANAVEX 2-73 for the treatment of Rett syndrome.--------------

The way I read it is that the Rett Syndrome Foundation is leaving the door open for additional grants if required to see this through; of course, early results will determine what they do. The key word: "a minimum of $0.6 million".